References
- https://covid19.who.int/ -accessed on 27 February 2022
- Li C, He Q, Qian H, Liu J. Overview of the pathogenesis of COVID 19 (Review). Exp Ther Med. 2021;22:1011.
- Barciszewska AM. Elucidating of oxidative distress in COVID-19 and methods of its prevention. Chemico Biol Interact. 2021;344:109501.
- Ntyonga-Pono MP. COVID-19 infection and oxidative stress: an under-explored approach for prevention and treatment. Pan Afr Med J. 2020;35:12.
- Gadotti AC, Lipinski AL, Vasconcellos FT, et al. Susceptibility of the patients infected with Sars-Cov2 to oxidative stress and possible interplay with severity of the disease. Free Radic Biol Med. 2021;165:184-190.
- Costela-Ruiz VJ, Illescas-Montes R, Puerta-Puerta JM, et al. SARS-CoV-2 infection: The role of cytokines in COVID-19 disease. Cytok Growth Fact Rev.2020;54:62–75.
- Laforge M, Elbim C, Frère C, et al. Tissue damage from neutrophil-induced oxidative stress in COVID-19. Nat Rev Immunol. 2020;20:515–516.
- Pincemail J, Cavalier E, Charlier C, Cheramy– Bien JP, Brevers E, Courtois A, et al. Oxidative Stress Status in COVID-19 Patients Hospitalized in Intensive Care Unit for Severe Pneumonia. A Pilot Study. Antioxidants. 2021;10:257.
- Atanasovska E, Petrusevska M, Zendelovska D, et al. Vitamin D levels and oxidative stress markers in patients hospitalized with COVID-19. Redox Rep. 2021;26:184-189.
- Zendelovska D, Atanasovska E, Petrushevska M, et al. Evaluation of oxidative stress markers in hospitalized patients with moderate and severe COVID-19. Rom J Intern Med. 2021;59:375-383.
- Petrushevska M, Zendelovska D, Atanasovska E, et al. Presentation of cytokine profile in relation to oxidative stress parameters in patients with severe COVID-19: a case-control pilot study. F1000Res. 2021;10:719.
- de Las Heras N, Martín Giménez VM, Ferder L, et al. Implications of Oxidative Stress and Potential Role of Mitochondrial Dysfunction in COVID-19: Therapeutic Effects of Vitamin D. Antioxidants. 2020;9:897.
- Carpagnano GE, Di Lecce V, Quaranta VN, et al. Vitamin D deficiency as a predictor of poor prognosis in patients with acute respiratory failure due to COVID-19. J Endocrinol Invest. 2021;44:765-771.
- D’Avolio A, Avataneo V, Manca A, et al. 25-Hydroxyvitamin D Concentrations Are Lower in Patients with Positive PCR for SARS-CoV-2. Nutrients. 2020;12:1359.
- Cuadrado A, Pajares M, Benito M, et al. Can activation of NRF2 be a strategy against COVID-19? Trends Pharmacol Sci. 2020;41:9.
- Gasparello J, D’Aversa E, Papi C, Gambari L, Grigolo B, et al. Sulforaphane inhibits the expression of interleukin-6 and interleukin-8 induced in bronchial epithelial IB3-1 cells by exposure to the SARS-CoV-2 Spike protein. Phytomedicine. 2021;87:153583.
- Bousquet J, Le Moing V, Blain H, et al. Efficacy of broccoli and glucoraphanin in COVID-19: From hypothesis to proof-of-concept with three experimental clinical cases. World Allergy Organ J. 2020;14(1):100498.
- Mahn A, Castillo A. Potential of sulforaphane as a natural immune system enhancer: A review. Moecules.2021;26:752.
- Kow CS, Ramachandram DS, Hasan SS. Use of sulforaphane in COVID-19: Clinical trials are needed. Mol Immunol. 2022;145:78-79.
- Ter Ellen BM, Kumar ND, Bouma EM, et al. Resveratrol and Pterostilbene Inhibit SARSCoV-2 Replication in Air-Liquid Interface Cultured Human Primary Bronchial Epithelial Cells. Viruses.2021;13:1335.
- Liao MT, Wu C, WU SV, et al. Resveratrol as an adjunctive therapy for excessive oxidative stress in aging COVID-19 patients. Antioxidants.2021;10:1440.
- Filardo S, Di Pietro M, Mastromarino P, Sessa R. Therapeutic potential of resveratrol against emerging respiratory viral infection. Pharmacol Therap. 2020;214:107613.
- Rahmadani LH, Bachari K. Potential therapeutic effects of resveratrol against SARS-CoV-2, Acta virol. 2020;64:276-280.
- Xiao Z, Ye Q, Duan X, Xiang T. Network pharmacology reveals that resveratrol can alleviate COVID-19 related hyperinflammation, Dis Markers. 2021;4129993.
- Pasquereau S, Nehme Z, Haidar Ahmad S, et al. Resveratrol Inhibits HCoV-229E and SARSCoV-2 Coronavirus Replication In Vitro. Viruses. 2021;23:354.
- Seo DJ, Choi C. Antiviral bioactive compounds of mushrooms and their antiviral mechanisms: a review. Viruses. 2021;13:50.
- Hetland G, Johnson E, Bernardshaw SV, Grinde, B. Can medicinal mushrooms have prophylactic or therapeutic effect against COVID-19 and its pneumonic superinfection and complicating inflammation. Scand J immunol. 2020;00:12937.
- Shahzad F, Anderson D, Najafzadeh M. The antiviral, anti-inflammatory effects of natural medicinal herbs and mushrooms and SARS-CoV-2 infection. Nutrients. 2020;12:2573.
- Suwannarach N, Kumla J, Sujarit K, et al. Natural Bioactive Compounds from Fungi as Potential Candidates for Protease Inhibitors and Immunomodulators to Apply for Coronaviruses. Molecules. 2020;25;1800.
- Gracian-Alcaide C, Maldonado-Lobon JA, Ortiz-Tikkakoski E, et al. Effects of a combination of elderberry and reishi extracts on the duration and severity of respiratory tract infections in elderly subjects: A randomized controlled trial. Appl Sci. 2020;10:8259.
- Habashy NH, Abu-Serie MM. The potential antiviral effect of major royal jelly protein2 and its isoform X1 against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Insight on their sialidase activity and molecular docking. J Funct Foods. 2020;75:104282.
- Ismail NF, Zulkifli MF, Ismail WIW. Therapeutic potentials of bee products for treatment of COVID-19. IMJM Med J Malaysia. 2021;21.
- Lima WG, Brito JCM, da Cruz Nizer WS. Bee products as a source of promising therapeutic and chemoprophylaxis strategies against COVID-19 (SARS-CoV-2), Phytother res. 2020;1-8.
- Todorovic N, Djordjevic N, Pajovic SB. In vitro analyses of antioxidant activity of food supplements GE Kids and Ge132+ Natural™, J Food Nutr Res. 2019;7:355-360.
- Immunomodulatory and antioxidant activities of Ge132+ Natural™ ™, VivaCell Biotechnology GmbH (2012) (unpublished results).
- Ho HPT, Vo DNK, Lin TY, et al. Ganoderma microsporum immunomodulatory protein acts as a multifunctional broad-spectrum antiviral against SARS-CoV-2 by interfering virus binding to the host cells and spike-mediated cell fusion. Biomed Pharmacother. 2022;155:113766.
- Cör Andrejč D, Knez Ž, Knez Marevci M. Anti-oxidant, antibacterial, antitumor, antifungal, antiviral, anti-inflammatory, and nevro-protective activity of Ganoderma lucidum: An overview. Front Pharmacol. 2022;13:934982.
- Ordonez AA, Bullen CK, Villabona-Rueda AF, et al. Sulforaphane exhibits antiviral activity against pandemic SARS-CoV-2 and seasonal HCoV-OC43 coronaviruses in vitro and in mice. Commun Biol. 2022;5(1):242.
- McCreary MR, Schnell PM, Rhoda DA. Randomized Double-blind Placebo-controlled Proof-of-concept Trial of Resveratrol for Out-patient Treatment of Mild Coronavirus Disease (COVID-19). Res Sq [Preprint]. 2021;861831.
- van Brummelen R, van Brummelen AC. The potential role of resveratrol as supportive anti-viral in treating conditions such as COVID-19 - A formulator’s perspective. Biomed Pharmacother. 2022;148:112767.
- Khongthaw B, Dulta K, Chauhan PK, et al. Lycopene: a therapeutic strategy against coronavirus disease 19 (COVID-19). Inflammopharmacology.2022;1–22.